to do list: 7/22
prepare some initial outputs for review next Friday

initial INR:
  change distribution
  change assignment

t2warfarin:
  wait for clarification in weibull distribution parameters

bleeding events:
  add minor bleeding event and adjust risks inputs (/4 to reflect INR duration shorter than 1 year)

DVTPE: 
  delete the part that randomly have people who experience non-fatal DVTPE to stop warfarin
  need to revise risks for non-AF 
  
INR testing:
  costs/disutility computation
  
when to release warfarin:
  does not matter after 90 days since genotyoped vs. non-genotyped groups converge.
  